These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32738423)

  • 1. Impact of prior authorizations on dermatology patients: A cross-sectional analysis.
    Guo LN; Nambudiri VE
    J Am Acad Dermatol; 2021 Jul; 85(1):217-220. PubMed ID: 32738423
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating the effect of prior authorizations in patients with complex dermatologic conditions.
    Jew OS; Okawa J; Barbieri JS; McCaffrey J; Hayward E; Werth VP
    J Am Acad Dermatol; 2020 Dec; 83(6):1674-1680. PubMed ID: 32622138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administrative Burden and Costs of Prior Authorizations in a Dermatology Department.
    Carlisle RP; Flint ND; Hopkins ZH; Eliason MJ; Duffin KC; Secrest AM
    JAMA Dermatol; 2020 Oct; 156(10):1074-1078. PubMed ID: 32845288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatology in the emergency department: Prescriptions, rates of inpatient admission, and predictors of high utilization in the United States from 1996 to 2012.
    Yang JJ; Maloney NJ; Bach DQ; Cheng K
    J Am Acad Dermatol; 2021 May; 84(5):1480-1483. PubMed ID: 32687969
    [No Abstract]   [Full Text] [Related]  

  • 5. Examining the prior authorization process, patient outcomes, and the impact of a pharmacy intervention: A single-center review.
    Popatia S; Flood KS; Golbari NM; Patel PV; Olbricht SM; Kimball AB; Porter ML
    J Am Acad Dermatol; 2019 Dec; 81(6):1308-1318. PubMed ID: 31103568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of COVID-19 on Dermatologic Practice, Disease Presentation, and Immunomodulator Prescriptions.
    Leis M; Fleming P; Lynde CW
    J Cutan Med Surg; 2021; 25(1):106-108. PubMed ID: 32936028
    [No Abstract]   [Full Text] [Related]  

  • 7. Advanced Therapy Treatment for Psoriasis: A Single-Site Retrospective Study of Prescribing Outcomes.
    Kim C; Joerg L; Levitt J
    Skinmed; 2017; 15(6):493-495. PubMed ID: 29282198
    [No Abstract]   [Full Text] [Related]  

  • 8. Association Between Method of Prescribing and Primary Nonadherence to Dermatologic Medication in an Urban Hospital Population.
    Adamson AS; Suarez EA; Gorman AR
    JAMA Dermatol; 2017 Jan; 153(1):49-54. PubMed ID: 27784045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing trends for biologic drugs among Ohio dermatologists.
    Iacullo J; Kunzler E; Ezaldein HH; Scott JF
    Dermatol Online J; 2018 Jul; 24(7):. PubMed ID: 30261565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy in dermatology: analysis of a nationally representative sample of 46,273 dermatology patient visits in the United States from 1995 to 2009.
    Gupta MA; Gupta AK; Fink NH
    Skinmed; 2013; 11(5):273-80. PubMed ID: 24340466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's new in dermatologic therapy.
    Thiers BH
    Dermatol Ther; 2008; 21(2):142-9. PubMed ID: 18394088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choosing dermatologic therapies.
    Wilkin J
    Dermatol Ther; 2009; 22(3):187-90. PubMed ID: 19453341
    [No Abstract]   [Full Text] [Related]  

  • 13. The Practice of Dermatology Ain't What It Used To Be: The Preauthorization Catastrophe.
    Parish LC; Parish JL; Lambert WC; Ciferni C
    Skinmed; 2019; 17(3):152-153. PubMed ID: 31496468
    [No Abstract]   [Full Text] [Related]  

  • 14. American Academy of Dermatology Annual Meeting: Washington, DC, USA, 1-5 March 2019.
    Fraser KA
    Am J Clin Dermatol; 2019 Apr; 20(2):307-310. PubMed ID: 30888668
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of methotrexate in pediatric dermatology].
    Mazereeuw-Hautier J; Uthurriague C
    Ann Dermatol Venereol; 2016 Feb; 143(2):154-61. PubMed ID: 26724843
    [No Abstract]   [Full Text] [Related]  

  • 16. [Off-label-use in dermatology].
    Sterry W
    J Dtsch Dermatol Ges; 2009 Nov; 7(11):931-2. PubMed ID: 19909390
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial.
    Jemec GBE; Lademann J; Braun S
    Dermatology; 2017; 233(4):259. PubMed ID: 29316557
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessing the Impact of Prior Authorizations on Dermatology Residents.
    Nussbaum D; Kalen J; McCormick E; Desai S; Friedman A
    J Drugs Dermatol; 2024 Jun; 23(6):485-488. PubMed ID: 38834217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichloroacetic acid in dermatology of 1911.
    Kopera D; Holubar K
    Int J Dermatol; 1998 Mar; 37(3):205. PubMed ID: 9556109
    [No Abstract]   [Full Text] [Related]  

  • 20. Hidradenitis suppurativa encounters in a national electronic health record database notable for low dermatology utilization, infrequent biologic prescriptions, and frequent opiate prescriptions.
    Wehner MR; Micheletti R; Noe MH; Linos E; Margolis DJ; Naik HB
    J Am Acad Dermatol; 2020 May; 82(5):1239-1241. PubMed ID: 31866261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.